<?xml version="1.0" encoding="UTF-8"?>
<p>The exploratory outcomes are as follows: (1) the incidence of hypertensive events (MBP &gt; 110 mmHg or â‰¥ 30% increase in MBP from baseline) during surgery, in the PACU, and within 3 postoperative days, (2) tachycardia or bradycardia events defined as HR &gt; 100 beats/min or HR &lt;50 beats/min, (3) intraoperative adverse events (arrythmia, hypoxia, allergic reaction, major bleeding, hyperthermia, hypothermia, oliguria, acid-base disturbances, electrolyte disorders, lactic acidosis, and cardiac arrest), (4) Ramsay sedation scores in the PACU, (5) numerical rating scale scores for pain, analgesic consumption, and postoperative nausea and vomiting (PONV) in the PACU and in the wards within three post-operative days, (6) time to extubation, (7) intensive care unit (ICU) admission, and (8) length of postoperative hospital stay.</p>
